THE LOW-HARM SCORE FOR PREDICTING MORTALITY IN PATIENTS DIAGNOSED WITH COVID-19: A MULTICENTRIC VALIDATION STUDY

Adrián Soto-Mota, Braulio A. Marfil‐Garza, Erick Martínez Rodríguez, José Omar Barreto Rodríguez, Alicia Estela López Romo, Paolo Alberti‐Minutti, Juan Vicente Alejandre Loya, Félix Emmanuel Pérez Talavera, Freddy José Ávila Cervera, Adriana Velazquez Burciaga,

medRxiv · 2020 · 10 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

ABSTRACT - Importance Many COVID-19 prognostic factors for disease severity have been identified and many scores have already been proposed to predict death and other outcomes. However, hospitals in developing countries often cannot measure some of the variables that have been reported as useful. - Objective To assess the sensitivity, specificity, and predictive values of the novel LOW-HARM score ( L ymphopenia, O xygen saturation, W hite blood cells, H ypertension, A ge, R enal injury, and M yocardial injury). - Design The score was designed using data from already published cohorts of patients diagnosed with COVID-19. Afterwards, it was calculated it in 438 consecutive hospital admissions at twelve different institutions in ten different cities in Mexico. - Setting Twelve hospitals in ten different cities in Mexico. - Participants Data from 438 patients was collected. Data from 400 patients (200 deaths and 200 survivors) was included in the analysis. - Exposure All patients had an infection with SARS-CoV-2 confirmed by PCR. - Main Outcome The sensitivity, specificity, and predictive values of different cut-offs of the LOW-HARM score to predict death. - Results Mean scores at admission and their distributions were significantly lower in patients who were discharged compared to those who died during their hospitalization 10 (SD: 17) vs 70 (SD: 28). The overall AUC of the model was 95%. A cut-off > 65 points had a specificity of 98% and a positive predictive value of 96%. More than a third of the cases (36%) in the sample had a LOW-HARM score > 65 points. - Conclusions and relevance The LOW-HARM score measured at admission is highly specific and useful for predicting mortality. It is easy to calculate and can be updated with individual clinical progression. KEY POINTS Question Is it possible to predict mortality in patients diagnosed with COVID-19 using easy-to-access and easy-to-measure variables? Findings The LOW-HARM score ( L ymphopenia, O xygen saturation, W hite blood cells, H ypertension, A ge, R enal injury, and M yocardial injury) is a one-hundred-point score that, when measured at admission, had an overall AUC of 95% for predicting mortality. A cut-off of ≥ 65 points had a specificity of 98% and a positive predictive value of 96%. Meaning The LOW-HARM score measured at admission is highly specific and useful for predicting mortality in patients diagnosed with COVID-19. In our sample, more than a third of patients met the proposed cut-off.

References

14